nafamostat has been researched along with Schwartzman Phenomenon in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Excerpt | Relevance | Reference |
|---|---|---|
| ", Forssman shock, Forssman cutaneous vasculitis, zymosan-induced paw edema, endotoxin shock and local Shwartzman reaction, FUT-175 was highly effective in that, for example, intravenous dosing at 3 mg/kg could completely protect guinea pigs from the lethal Forssman shock." | 1.27 | Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments. ( Aoyama, T; Fujita, M; Ino, Y; Koshiyama, Y; Oda, M; Ozeki, M; Sato, T; Suzuki, S, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, T | 1 |
| Ino, Y | 1 |
| Ozeki, M | 1 |
| Oda, M | 1 |
| Sato, T | 1 |
| Koshiyama, Y | 1 |
| Suzuki, S | 1 |
| Fujita, M | 1 |
1 other study available for nafamostat and Schwartzman Phenomenon
| Article | Year |
|---|---|
Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.
Topics: Animals; Anti-Inflammatory Agents; Benzamidines; Complement Activation; Complement Inactivator Prote | 1984 |